Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)
Clinical trial NCT03364036 · COMPLETED
Trial details
- NCT number
- NCT03364036
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-28
- Primary completion
- 2020-05-05
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.